Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]

Optimal use of asparaginase for acute lymphoblastic leukaemia

Dr Ibrahim Aldoss - City of Hope, Duarte, USA

Optimal use of asparaginase for acute lymphoblastic leukaemia ( Dr Ibrahim Aldoss - City of Hope, Duarte, USA )

Mobile supportive care for children and young adults with ALL

Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria

Mobile supportive care for children and young adults with ALL ( Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria )

Post-HSCT management of paediatric patients with ALL

Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria

Post-HSCT management of paediatric patients with ALL ( Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria )

Immunotherapy of T-ALL: Opportunities and hurdles

Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA

Immunotherapy of T-ALL: Opportunities and hurdles ( Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA )

Workshop diagnostics procedures in ALL

Prof Robin Foà - Sapienza University of Rome, Rome, Italy

Workshop diagnostics procedures in ALL ( Prof Robin Foà - Sapienza University of Rome, Rome, Italy )

Practical applications on new data of genetic ALL subtypes

Prof Robin Foà - Sapienza University of Rome, Rome, Italy

Practical applications on new data of genetic ALL subtypes ( Prof Robin Foà - Sapienza University of Rome, Rome, Italy )

Triple class refractory multiple myeloma

Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix...

$Triple class refractory multiple myeloma ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )$

Managing high-risk/MRD positive and standard-risk/MRD myeloma

Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy

Managing high-risk/MRD positive and standard-risk/MRD myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )

Minimum residual disease techniques in myeloma

Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy

Minimum residual disease techniques in myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )

Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma

Prof Wee Joo Chng - National University Cancer Institute, Singapore

Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma ( Prof Wee Joo Chng - National University Cancer Institute, Singapore )

High-risk SMM imaging and NDMM treatment

Dr Elena Zamagni - University of Bologna, Bologna, Italy

High-risk SMM imaging and NDMM treatment ( Dr Elena Zamagni - University of Bologna, Bologna, Italy )

Rescue after daratumumab failure

Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix...

Rescue after daratumumab failure ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )

More from ecancer